Market Research Report
Communicable Disease Market: A BCC Research Overview
|Published by||BCC Research||Product code||900629|
|Published||Content info||151 Pages
Delivery time: 1-2 business days
|Communicable Disease Market: A BCC Research Overview|
|Published: July 31, 2019||Content info: 151 Pages||
The global market for communicable disease should grow from $57.7 billion in 2019 to $69.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.8% for the period of 2019-2024.
North American market for communicable disease should grow from $21.9 billion in 2019 to reach $25.9 billion by 2024 at a CAGR of 3.4% for the period of 2019-2024.
Asia-Pacific market for communicable disease should grow from $11.7 billion in 2019 to reach $14.9 billion by 2024 at a CAGR of 5.0% for the period of 2019-2024.
The scope of this report is broad and covers therapeutics used in treatment of communicable diseases. The report highlights the current and future market potential of communicable diseases therapeutics and provides a detailed analysis of the competitive environment, regulations, epidemiology of communicable diseases, merger and acquisition, drivers, restraints, and pipeline drugs in the market. The report also covers market projections through 2024.
The report details market shares of communicable diseases based on different disease indication. Based on disease indication the market is segmented into HIV, Hepatitis B&C, Herpes Simplex Virus, Influenza, Malaria, Tuberculosis, and Others.
The market is segmented by geography into the following regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. The report presents detailed analyses of major countries such as the U.S., Canada, Mexico, Germany, the U.K. France, Spain, Italy, Japan, China and India. For market estimates, data is provided for 2018 as the base year, with forecasts for 2019 through 2024. Estimated values are based on product manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.